Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Market Cap | $47 | $161 | $37 | $37 |
| - Cash | $49 | $74 | $9 | $5 |
| + Debt | $30 | $0 | $0 | $0 |
| Enterprise Value | $29 | $87 | $28 | $32 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$76 | -$48 | -$21 | -$11 |
| % Margin | – | – | – | – |
| Net Income | -$73 | -$51 | -$22 | -$11 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.59 | -5.19 | -11.23 | -5.81 |
| % Growth | 30.8% | 53.8% | -93.3% | – |
| Operating Cash Flow | -$62 | -$41 | -$18 | -$10 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$62 | -$41 | -$18 | -$10 |